| 1 | [SID85148896] | Active | IC50 | 2.14 | Dose response confirmation of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a kinetic, fluorescence intensity assay [AID624326, Type: confirmatory] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | IC50 | 2.14 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a kinetic, fluorescence intensity assay | | AID | 624326 | | BioAssay type | confirmatory | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 2 | [SID85148896] | Active | IC50 | 2.14 | Dose response confirmation of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a kinetic, fluorescence intensity assay [AID624326, Type: confirmatory] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | IC50 | 2.14 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a kinetic, fluorescence intensity assay | | AID | 624326 | | BioAssay type | confirmatory | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 3 | [SID85148896] | Active | IC50 | 2.14 | Dose response confirmation of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a kinetic, fluorescence intensity assay [AID624326, Type: confirmatory] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | IC50 | 2.14 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a kinetic, fluorescence intensity assay | | AID | 624326 | | BioAssay type | confirmatory | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 4 | [SID85148896] | Active | IC50 | 2.65 | Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID624327, Type: confirmatory] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | IC50 | 2.65 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 624327 | | BioAssay type | confirmatory | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 5 | [SID85148896] | Active | IC50 | 2.65 | Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID624327, Type: confirmatory] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | IC50 | 2.65 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 624327 | | BioAssay type | confirmatory | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 6 | [SID85148896] | Active | IC50 | 2.65 | Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID624327, Type: confirmatory] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | IC50 | 2.65 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 624327 | | BioAssay type | confirmatory | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 7 | [SID85148896] | Active | Potency | 35.4813 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 8 | [SID85148896] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2233 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 9 | [SID85148896] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2233 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 10 | [SID85148896] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 11 | [SID85148896] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|
| 12 | [SID85148896] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID624325, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 624325 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 13 | [SID85148896] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID624325, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 624325 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 14 | [SID85148896] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID624325, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 624325 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 15 | [SID85148896] | Active | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 16 | [SID85148896] | Active | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 17 | [SID85148896] | Active | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 18 | [SID85148896] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID85148896] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 20 | [SID85148896] | Inactive | Potency | 0.0465 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | 0.0465 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID85148896] | Inactive | Potency | 5.6234 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 22 | [SID85148896] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 23 | [SID85148896] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 24 | [SID85148896] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 25 | [SID85148896] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 26 | [SID85148896] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 27 | [SID85148896] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 28 | [SID85148896] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 29 | [SID85148896] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 30 | [SID85148896] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 31 | [SID85148896] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 32 | [SID85148896] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 33 | [SID85148896] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 34 | [SID85148896] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 35 | [SID85148896] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 36 | [SID85148896] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 37 | [SID85148896] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 38 | [SID85148896] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 39 | [SID85148896] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 40 | [SID85148896] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 41 | [SID85148896] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 42 | [SID85148896] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 43 | [SID85148896] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 44 | [SID85148896] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 45 | [SID85148896] | Inactive | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 46 | [SID85148896] | Inactive | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 47 | [SID85148896] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [AID602410, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 | | AID | 602410 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 48 | [SID85148896] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 49 | [SID85148896] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 50 | [SID85148896] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85148896 | | CID | 44144090 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|